Cardiac Transplantation: Any Role Left?

Martin Cadeiras, Manuel Prinz von Bayern, Mario C. Deng

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


The authors analyze the question of whether heart transplantation still has a role in the current era of complex technologies. To achieve this objective, the authors first discuss the known benefits of different therapeutic modalities currently available for patients who have end-stage heart failure, including pharmacologic management, electrophysiologic therapies, high-risk surgical strategies, implantation of mechanical circulatory support device therapy, and heart transplantation. The authors then evaluate the current developments and future perspectives in the field that may influence the likelihood of heart transplantation to remain the therapeutic modality of choice for end-stage heart failure.

Original languageEnglish (US)
Pages (from-to)321-347
Number of pages27
JournalHeart Failure Clinics
Issue number3
StatePublished - Jul 1 2007
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Cardiac Transplantation: Any Role Left?'. Together they form a unique fingerprint.

Cite this